Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
1.
J Endourol ; 2024 May 30.
Artículo en Inglés | MEDLINE | ID: mdl-38815140

RESUMEN

Background/Aim: To evaluate the performance of Chat Generative Pre-trained Transformer (ChatGPT), a large language model trained by Open artificial intelligence. Materials and Methods: This study has three main steps to evaluate the effectiveness of ChatGPT in the urologic field. The first step involved 35 questions from our institution's experts, who have at least 10 years of experience in their fields. The responses of ChatGPT versions were qualitatively compared with the responses of urology residents to the same questions. The second step assesses the reliability of ChatGPT versions in answering current debate topics. The third step was to assess the reliability of ChatGPT versions in providing medical recommendations and directives to patients' commonly asked questions during the outpatient and inpatient clinic. Results: In the first step, version 4 provided correct answers to 25 questions out of 35 while version 3.5 provided only 19 (71.4% vs 54%). It was observed that residents in their last year of education in our clinic also provided a mean of 25 correct answers, and 4th year residents provided a mean of 19.3 correct responses. The second step involved evaluating the response of both versions to debate situations in urology, and it was found that both versions provided variable and inappropriate results. In the last step, both versions had a similar success rate in providing recommendations and guidance to patients based on expert ratings. Conclusion: The difference between the two versions of the 35 questions in the first step of the study was thought to be due to the improvement of ChatGPT's literature and data synthesis abilities. It may be a logical approach to use ChatGPT versions to inform the nonhealth care providers' questions with quick and safe answers but should not be used to as a diagnostic tool or make a choice among different treatment modalities.

2.
Urology ; 173: 159-163, 2023 03.
Artículo en Inglés | MEDLINE | ID: mdl-36642118

RESUMEN

OBJECTIVE: To develop a near-infrared (NIR) spectroscopy device to diagnose testicular torsion with high sensitivity and specificity. Specifically, we aim to investigate the differentiation between testicular torsion from other pathologies such as orchidoepididymitis, varicocele, and hydrocele. METHODS: Two LEDs with wavelengths of 660 nm and 940 nm were used as light sources in the device. Each wavelength was sent to the testicle successively, and a photodiode detected back-reflected diffuse light. The ratio of the light intensities of 660 nm and 940 nm was used as a diagnostic parameter. A multi-center clinical trial was performed in 5 different hospitals. RESULTS: In total, 62 patients in urology clinics with acute testicular pain have been recruited for the study. The developed NIR spectroscopy correctly defined all 8 testicular torsion cases. Besides, 3 orchidoepididymitis, 1 varicocele, and 3 hydrocele cases were correctly distinguished from testicular torsion. Only 1 hydrocele case was misdiagnosed as torsion. The range of the ratio was between 0.14 and 1.16 overall measurements. The ratio varied between 0.14 and 0.3 for the testicle with torsion. The ratio was between 0.49 and 1.16 for the normal testicle and testicle with other pathologies mentioned above. CONCLUSION: We have chosen the threshold ratio of 0.4 to differentiate between the normal and torsion testis and diagnosed all the torsion cases among all normal and other pathologies. The developed optical device to diagnose testicular torsion is inexpensive, user-friendly, and works based on objective criteria with high sensitivity and specificity in real time.


Asunto(s)
Dolor Agudo , Torsión del Cordón Espermático , Enfermedades Testiculares , Hidrocele Testicular , Varicocele , Humanos , Masculino , Espectroscopía Infrarroja Corta , Torsión del Cordón Espermático/diagnóstico , Testículo , Varicocele/diagnóstico
3.
Andrology ; 10(6): 1038-1046, 2022 09.
Artículo en Inglés | MEDLINE | ID: mdl-34994082

RESUMEN

BACKGROUND: Angiotensin-converting enzyme 2 and transmembrane protease serine 2 are critical factors of virus transmission. Expression of angiotensin-converting enzyme 2 is highest in testes, and testicular function and testosterone levels were affected by coronavirus disease 2019. Low testosterone levels are related to infections, especially respiratory tract infections, and could worsen clinical conditions by exacerbating cytokine storms and increasing pro-inflammatory cytokines. OBJECTIVES: We aimed to evaluate the acute and chronic effects of coronavirus disease 2019 on gonadal functions. Our second aim was to detect the relationship between free testosterone levels and disease prognosis and determine the impact of low-free testosterone on admission to the intensive care unit. METHODS: Eighty-one patients with reverse-transcription polymerase chain reaction-confirmed coronavirus disease 2019 were enrolled. Twenty-nine patients were assessed again for 6 months post-coronavirus disease 2019 follow-up, and seven of them had a semen analysis. Serum follicle-stimulating hormone, luteinizing hormone, sex hormone-binding globulin, and total testosterone levels were measured. RESULTS: In this observational study, 71.6% (n = 58) of patients had low free testosterone levels at baseline, in which 69% were considered secondary hypogonadism. A longer length of hospitalization and increased inflammatory markers (d-dimer, high-sensitive C-reactive protein, and procalcitonin) were detected in the low-free testosterone group. Follicle-stimulating hormone, total, free, and bioavailable testosterone levels were lower in patients who required admission to the intensive care unit. Free testosterone levels were inversely correlated with the length of hospitalization and prognostic disease factors. Oligozoospermia and impaired progressive motility were present in 42.8% (3/7) of the patients. In 6 months post-coronavirus disease 2019 follow-up, out of 29 patients, 48.2% still had low testosterone levels. CONCLUSION: A high rate of hypogonadism (71.6%) was found, especially secondary hypogonadism, and about half of the patients had hypogonadism in the sixth months' follow-up. Low free testosterone levels were correlated with inflammatory parameters, and it is related to the intensive care unit admission. Studies with long-term follow-up data in larger groups are needed to determine persistent hypogonadism and impaired spermatogenesis.


Asunto(s)
COVID-19 , Hipogonadismo , Enzima Convertidora de Angiotensina 2 , Hormona Folículo Estimulante , Humanos , Masculino , Testosterona
4.
Arch Ital Urol Androl ; 92(3)2020 Oct 02.
Artículo en Inglés | MEDLINE | ID: mdl-33016055

RESUMEN

OBJECTIVES: T1 bladder cancer has a wide range of tumor behavior and lamina propria invasion depth has a high potential risk of disease progression. To evaluate the patient outcome according to the tumor invasion to the muscularis mucosae-vascular plexus (MM-VP) in pT1 bladder urothelial carcinoma (BUC). MATERIALS AND METHODS: This study is a retrospective analysis of patients consecutively recorded from 2007 to 2013. A total of 93 patients with a history of primary pT1 BUC and complete follow-up were included. We used a pathological substaging system according to the tumor invasion regarding the MM-VP: pT1a (invasion above MM-VP) and pT1b (MM-VP invasion). We evaluated recurrence-free survival (RFS), progression- free survival (PFS), disease-specific-survival (DSS) based on this sub-staging system. RESULTS: Pathological evaluation regarding the MM-VP invasion revealed 53 patients (57%) as pT1a BUC and 40 patients (43%) as pT1b BUC. The mean follow-up was 78.8 months. During the follow-up period; 60 patients (64.5%) had tumor recurrences, 32 patients (34.4%) had progression to invasive disease, 18 patients (19.4 %) died during follow-up related to the BUC. In 29 (54.7%) of pT1a and in 31(77.5%) of pT1b tumors, the recurrent disease was recorded during the followup period (p = 0.023). DSS rates at 5 years for pT1a and pT1b were 80.2% and 60.8%, respectively. PFS, RFS, and DSS rates were similar for pT1a/pT1b and did not reach statistical significance (p > 0.05). CONCLUSIONS: Sub-staging of pT1 BUC according to the MM-VP invasion showed a limited impact on the outcome in our patient cohort. However, the presence of pT1b disease caused a significantly higher rate of recurrence.


Asunto(s)
Carcinoma de Células Transicionales/patología , Neoplasias de la Vejiga Urinaria/patología , Anciano , Carcinoma de Células Transicionales/mortalidad , Femenino , Humanos , Masculino , Persona de Mediana Edad , Membrana Mucosa/patología , Músculo Liso/patología , Invasividad Neoplásica , Estudios Retrospectivos , Tasa de Supervivencia , Neoplasias de la Vejiga Urinaria/mortalidad
6.
Asian Pac J Cancer Prev ; 14(9): 5107-10, 2013.
Artículo en Inglés | MEDLINE | ID: mdl-24175784

RESUMEN

BACKGROUND: Among women with haematuria, defining individuals under high risk for bladder cancer based on reproductive factors prior to cystoscopy would be of great benefit in the management of this condition. The aim of this study was to compare age and reproductive factors such as menopausal status, parity, age at first delivery and age at the last delivery between women who have haematuria with or without bladder cancer. MATERIALS AND METHODS: A total of 463 patients underwent diagnostic cystoscopy in Duzce University Faculty of Medicine between 1 June 2008 and 1 June 2013. Female patients who presented with persistent microscopic or macroscopic haematuria and underwent standard evaluation for haematuria including urinalysis, urine culture, urine cytology, urinary tract imaging with excretory urography or computerized tomography with contrast enhancement and endoscopic evaluation of the urethra and bladder were included in this study. Exclusion criteria were tobacco use and high risk occupations for bladder cancer such as textile, dry cleaning, painting and etc. Fourteen women had hematuria due to benign conditions, and 18 due to bladder cancer. Data were retrospectively retrieved from the medical records of Duzce University Hospital. RESULTS: Patients with haematuria due to benign reasons did not significantly differ from patients who were found to have bladder cancer in terms of age (p=0.28), menopausal status (p=0.29), mean parity (p=0.38), being nulliparous (p=0.57), parity ≥ 3 (p=0.22), age ≤ 18 years at first delivery (p=1.00), age ≥ 30 years at last delivery (p=0.26), age ≥ 35 years at last delivery (p=0.23) and percentage of the patients with advanced age (≥ 65 years) (p=0.18). CONCLUSIONS: It is difficult to predict a high risk for developing bladder cancer in women with haematuria based solely on reproductive factors.


Asunto(s)
Carcinoma de Células Transicionales/epidemiología , Hematuria/epidemiología , Menopausia , Paridad , Historia Reproductiva , Neoplasias de la Vejiga Urinaria/epidemiología , Adenocarcinoma/complicaciones , Adenocarcinoma/diagnóstico , Adenocarcinoma/epidemiología , Adulto , Factores de Edad , Anciano , Anciano de 80 o más Años , Carcinoma de Células Transicionales/complicaciones , Carcinoma de Células Transicionales/diagnóstico , Estudios de Cohortes , Cistoscopía , Femenino , Hematuria/diagnóstico , Hematuria/etiología , Humanos , Persona de Mediana Edad , Estudios Retrospectivos , Medición de Riesgo , Factores de Riesgo , Sarcoma/complicaciones , Sarcoma/diagnóstico , Sarcoma/epidemiología , Tomografía Computarizada por Rayos X , Urinálisis , Neoplasias de la Vejiga Urinaria/complicaciones , Neoplasias de la Vejiga Urinaria/diagnóstico
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA